Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Kinesio Taping and Physiotherapeutic Exercises for Children With DCD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04123912
Recruitment Status : Not yet recruiting
First Posted : October 11, 2019
Last Update Posted : October 11, 2019
Sponsor:
Information provided by (Responsible Party):
Shirley S.M. Fong, The University of Hong Kong

Brief Summary:

Aim: To investigate the effectiveness of a novel elastic taping-augmented functional movement power training (KT-FMPT) program in improving leg muscular performance, body balance, motor proficiency and functional independence in children with developmental coordination disorder (DCD).

Methodology: In this clinical trial, twenty children with DCD (aged 6-12) will be randomly assigned to either a KT-FMPT group or a placebo control group. Children in the KT-FMPT and control groups will receive elastic taping-augmented FMPT and general jogging exercise with non-elastic taping, respectively, for 12 weeks (2 hours/week). Major outcome measures: body balance and leg muscle activity will be measured via muscle sensors along with a force platform. Secondary outcome measures: leg muscle strength, motor proficiency and functional independence will be assessed by a digital dynamometer, the Movement Assessment Battery for Children-2 and Pediatric Evaluation of Disability Inventory, respectively (before- and after-intervention measurements).

Significance: The KT-FMPT group is predicted to display much better muscular and motor performances than the control group. This novel training program can be readily adopted in clinical, school, or home settings to improve functional independence in children with DCD, an outcome with positive socioeconomic implications. Moreover, study findings will inspire future research work in children with other childhood-onset disabilities.


Condition or disease Intervention/treatment Phase
Developmental Coordination Disorder Behavioral: Kinesio Taping - Functional Movement Power Training Behavioral: Jogging with placebo taping Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of Kinesio Taping and Functional Movement Power Training on Neuromuscular Performance, Motor Proficiency and Functional Independence in Children With Developmental Coordination Disorder: A Randomised Controlled Trial
Estimated Study Start Date : January 1, 2020
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2022

Arm Intervention/treatment
Experimental: KT-FMPT group Behavioral: Kinesio Taping - Functional Movement Power Training
Subjects assigned to the Kinesio Taping - Functional Movement Power Training (KT-FMPT) group will receive FMPT concurrent with KT. The FMPT protocol was developed by the research team with reference to common physiotherapeutic exercises for children with motor disabilities.9 It comprises 5 functional movement exercises and 6 lower-limb power/resistance training exercises using weights or resistance bands.

Placebo Comparator: Control group Behavioral: Jogging with placebo taping
Subjects assigned to the control group will receive no FMPT or KT, but participate in a jogging intervention with placebo tape applied on their calf muscles and removed after the intervention.




Primary Outcome Measures :
  1. Change in leg muscle electromyographic activation onset latency time (in ms) [ Time Frame: 0 and 3 months ]
    Electromyographic activation onset of leg muscles

  2. Change in centre of pressure movement pathway in standing (in mm/cm) [ Time Frame: 0 and 3 months ]
    Centre of pressure movement pathway in standing


Secondary Outcome Measures :
  1. Change in lower-extremity maximum isometric muscle strength (in kg/N) [ Time Frame: 0 and 3 months ]
    Maximum isometric leg muscle strength

  2. Change in Movement Assessment Battery for Children-2 percentile score [ Time Frame: 0 and 3 months ]
    Movement Assessment Battery for Children-2 percentile (motor proficiency)

  3. Change in Pediatric Evaluation of Disability Inventory score [ Time Frame: 0 and 3 months ]
    Pediatric Evaluation of Disability Inventory score (functional independence)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 6- to 12-years-old
  • classified as DCD according to the Diagnostic and Statistical Manual of Mental Disorders V
  • score < 5th percentile on the Movement Assessment Battery for Children, 2nd edition (MABC-2)
  • total score < 46 on the DCD questionnaire (2007)
  • attending a mainstream primary school with intelligence level within the normal range
  • no KT or FMPT experience

Exclusion Criteria:

  • any known congenital, cognitive, psychiatric, neurological, sensorimotor, musculoskeletal or cardiopulmonary disorder that may affect test performance
  • receiving active rehabilitation treatment
  • demonstrating excessive disruptive behaviour
  • unable to follow instructions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04123912


Locations
Layout table for location information
Hong Kong
University of Hong Kong
Hong Kong, Hong Kong
Sponsors and Collaborators
The University of Hong Kong

Layout table for additonal information
Responsible Party: Shirley S.M. Fong, Dr, The University of Hong Kong
ClinicalTrials.gov Identifier: NCT04123912     History of Changes
Other Study ID Numbers: 0001
First Posted: October 11, 2019    Key Record Dates
Last Update Posted: October 11, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Motor Skills Disorders
Neurodevelopmental Disorders
Mental Disorders